Holen Sie sich die Stockscreener-App
135.35
6.82%
8.64
Schlusskurs vom Vortag:
$126.71
Offen:
$128.38
24-Stunden-Volumen:
1.54M
Relative Volume:
0.87
Marktkapitalisierung:
$6.97B
Einnahmen:
$43.41B
Nettoeinkommen (Verlust:
$1.13B
KGV:
6.6744
EPS:
20.279
Netto-Cashflow:
$427.00M
1W Leistung:
+2.76%
1M Leistung:
-25.19%
6M Leistung:
-16.04%
1J Leistung:
-49.99%
1-Tages-Spanne:
$128.38
$135.38
1-Wochen-Bereich:
$121.06
$135.94
52-Wochen-Spanne:
$121.06
$359.97
Molina Healthcare Inc Stock (MOH) Company Profile
Firmenname
Molina Healthcare Inc
Sektor
Branche
Telefon
(562) 435-3666
Adresse
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MOH
Molina Healthcare Inc
|
135.35 | 6.53B | 43.41B | 1.13B | 427.00M | 20.28 |
|
UNH
Unitedhealth Group Inc
|
293.19 | 257.59B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.48 | 99.14B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
291.44 | 75.77B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
346.80 | 74.17B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
184.10 | 21.51B | 126.36B | 1.30B | 1.55B | 10.67 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-10-16 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-25 | Herabstufung | Truist | Buy → Hold |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-04-22 | Eingeleitet | Bernstein | Outperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-03 | Fortgesetzt | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-11-22 | Fortgesetzt | Deutsche Bank | Hold |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Underweight |
| 2021-03-30 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-10 | Eingeleitet | Mizuho | Buy |
| 2021-02-19 | Fortgesetzt | Barclays | Overweight |
| 2021-01-21 | Eingeleitet | Goldman | Neutral |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-16 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2020-04-08 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2019-10-30 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-07-31 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-03 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-05-31 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-04-30 | Bestätigt | BofA/Merrill | Underperform |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-13 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-10 | Eingeleitet | Evercore ISI | In-line |
| 2018-06-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-06-22 | Hochstufung | Jefferies | Hold → Buy |
| 2018-03-28 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-16 | Hochstufung | JP Morgan | Neutral → Overweight |
Alle ansehen
Molina Healthcare Inc Aktie (MOH) Neueste Nachrichten
DDD Partners LLC Acquires Shares of 9,107 Molina Healthcare, Inc $MOH - MarketBeat
Molina Healthcare (MOH) PT Lowered to $124 by Goldman Sachs Following Q4 Earnings Miss - Yahoo Finance
Is Molina Healthcare Inc. a top pick in the sectorWeekly Trade Report & Daily Risk Controlled Trade Plans - mfd.ru
Molina Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Looking Into Molina Healthcare Inc's Recent Short Interest - Benzinga
Molina Healthcare (MOH) Q4 Loss And Margin Compression Challenge Bullish Earnings Narratives - Sahm
Bullish Move: Richard C Zoretic Shows Confidence, Acquires $100K In Molina Healthcare Stock - Benzinga
Molina Healthcare, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance
Is Molina Healthcare Inc. stock supported by innovation pipeline2025 AllTime Highs & Capital Protection Trade Alerts - mfd.ru
Goldman Sachs Adjusts Molina Healthcare (MOH) Price Target | MOH Stock News - GuruFocus
Molina Healthcare Inc (MOH) Shares Up 4.47% on Feb 12 - GuruFocus
Molina Healthcare (NYSE:MOH) Reaches New 1-Year LowWhat's Next? - MarketBeat
Wealthfront Advisers LLC Reduces Stake in Molina Healthcare, Inc $MOH - MarketBeat
Long-Term Investors in shares of Molina Healthcare, Inc. (NYSE: - openPR.com
Molina Healthcare's Q4 Earnings Call: Our Top 5 Analyst Questions - Finviz
Molina Healthcare’s Margins at Risk as Medicaid Rates Lag Rising Medical Costs - TipRanks
Goldman Sachs Adjusts PT on Molina Healthcare to $124 From $167, Maintains Neutral Rating - marketscreener.com
Molina Healthcare, Inc. (NYSE:MOH) Might Not Be As Mispriced As It Looks After Plunging 31% - simplywall.st
Investment Management Associates Inc. ADV Makes New $20.24 Million Investment in Molina Healthcare, Inc $MOH - MarketBeat
Decoding Molina Healthcare Inc (MOH): A Strategic SWOT Insight - GuruFocus
Barclays Lowers Molina Healthcare (MOH) Price Target to $133 | M - GuruFocus
Important Notice to Long-Term Shareholders of Integer - GlobeNewswire
Deutsche Bank Cuts Price Target on Molina Healthcare to $109 From $165, Keeps Hold Rating - marketscreener.com
Barclays Adjusts Price Target on Molina Healthcare to $133 From $164, Maintains Underweight Rating - marketscreener.com
Molina Healthcare (MOH) Valuation After Quarterly Loss And Exit From Medicare Advantage Drug Plans - Sahm
The Analyst Verdict: Molina Healthcare In The Eyes Of 5 Experts - Benzinga
Molina Healthcare (NYSE:MOH) Given New $144.00 Price Target at TD Cowen - MarketBeat
UBS Lowers Molina Healthcare Price Target to $145 From $170, Maintains Neutral Rating - marketscreener.com
Molina Healthcare (MOH): Cantor Fitzgerald Maintains Neutral Rat - GuruFocus
Molina Healthcare Options Trading: A Deep Dive into Market Sentiment - Benzinga
Important Notice to Long-Term Shareholders of Molina Healthcare, Inc. (MOH): Grabar Law Office Investigates Claims on Your Behalf - TMX Newsfile
Molina Healthcare (NYSE:MOH) Price Target Lowered to $144.00 at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Adjusts Molina Healthcare Price Target to $144 From $180, Maintains Neutral Rating - marketscreener.com
Jefferies Adjusts Price Target on Molina Healthcare to $139 From $160, Maintains Hold Rating - marketscreener.com
What Molina’s Medicare Advantage exit says about the market - Modern Healthcare News
TD Cowen Adjusts Price Target on Molina Healthcare to $144 From $175, Maintains Hold Rating - marketscreener.com
Molina Healthcare Earnings Call: Growth Wins vs. Strain - TipRanks
Molina Healthcare, Coty, Illumina, Amazon and other big stocks moving lower in Friday's pre-market session - MSN
Molina Healthcare Loss Highlights Medicaid Risks And Potential Valuation Opportunity - Yahoo Finance
Molina Healthcare Crashed 26% on Earnings Disaster: Can the $187 Value Gap Close in 2026? - TIKR.com
Earnings Miss: Molina Healthcare, Inc. Missed EPS By 24% And Analysts Are Revising Their Forecasts - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Molina Healthcare: Still Not Buying This Sick Puppy (NYSE:MOH) - Seeking Alpha
Molina Healthcare, Inc. (NYSE:MOH) Q4 2025 Earnings Call Transcript - Insider Monkey
Molina Healthcare Falls After Q4 Loss, Higher Medical Costs; Issues Muted 2026 Profit View - AlphaStreet News
Looking At The Narrative For Molina Healthcare (MOH) As Contracts And Policy Reset Expectations - Yahoo Finance
Molina Healthcare Q4 Earnings Call Highlights - MarketBeat
Molina Healthcare (MOH) Announces Amendments to Credit Agreement and Strategic Shift - GuruFocus
Molina Healthcare to record $93 million impairment, amends credit agreement - Investing.com
JP Morgan Reduces PT on Molina Healthcare (MOH) to $333 From $350, Keeps a Hold Rating - MSN
Molina Healthcare Announces Impairment Charge Amid Medicare Shift - TipRanks
Finanzdaten der Molina Healthcare Inc-Aktie (MOH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.70%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):